In this article, we will look at the 10 Best 52-Week Low Penny Stocks to Buy Now.
On March 26, Gabelli released its Small Cap Outlook for 2025 and beyond. The firm highlighted small-cap stocks as an attractive investment opportunity, noting that the sector has been undervalued compared to large-cap stocks, especially mega-cap tech companies. This has created a wide valuation gap that has the potential to benefit long-term investors who seek diversification.
The positive outlook of Gabelli for the small caps is based on numerous factors, including current valuations, economic conditions, and key industry trends like increased mergers and acquisitions, reshoring of manufacturing, and tax or regulatory changes. The firm notes that despite inflation and interest rate pressures, this sector has shown resilience.
Moreover, from 2010 to 2017, the Russell 2000 had generally traded at higher forward P/E multiples than large caps. However, the valuation gap shifted since 2018, when the large caps gained a significant premium. More recently, in 2023, the Russell 1000 outperformed the Russell 2000 with total returns of 26.5% versus 16.9%, respectively. Large-cap growth stocks, powered by mega-cap tech and AI beneficiaries, continued to lead returns, while the small-cap value showed relative strength but did not close the overall gap. The report highlighted that the earnings growth forecasts for the Russell 2000 have remained elevated, supporting the idea that the performance gap is narrowing. Therefore, the persistent valuation discount for small caps, combined with stabilizing earnings and broadening economic growth, suggests that small caps may be poised for relative outperformance going forward.
With that, let’s take a look at the 10 best 52-week low penny stocks to buy now.
A trader working diligently at her desk, evaluating stocks of multiple industries.
Our Methodology
To curate the list of 10 best 52-week low penny stocks to buy now, we used the Finviz stock screener, Yahoo Finance, and CNN as our sources. Using the screener, we aggregated a list of penny stocks (below $5) trading at 0% to 5% of their 52-week lows with an upside potential of at least 50%. Next, we cross-checked the stock price and 52-week ranges from Yahoo Finance and analyst upside potential from CNN. Lastly, we ranked the stocks in ascending order of the number of hedge fund holders sourced from Insider Monkey’s Q1 2025 database.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
10 Best 52-Week Low Penny Stocks to Buy Now
10. Waldencast plc (NASDAQ:WALD)
Price: $1.74
52-Week Range: $1.68 – $4.74
Analyst Upside Potential: 129.89%
Number of Hedge Fund Holders: 10
Waldencast plc (NASDAQ:WALD) is one of the Best 52-Week Low Penny Stocks to Buy Now. On July 23, Waldencast plc (NASDAQ:WALD) announced the acquisition of Novaestiq Corp. and the US rights to the Saypha line of hyaluronic acid injectable gels.
This strategic acquisition expands Obagi Medical’s offerings beyond skincare into the dermal filler market in the US. Management noted that the skincare market is expected to reach $2.2 billion by 2029, while the dermal filler market is projected at $2 billion. The acquisition doubles the company’s addressable market.
Waldencast plc (NASDAQ:WALD) will now offer injectable HA gels named Saypha to integrate medical-grade skincare with aesthetic treatments for better, longer-lasting results and higher patient satisfaction.
Waldencast plc (NASDAQ:WALD) is an international beauty and wellness company that develops purpose-driven brands.
9. MaxCyte, Inc. (NASDAQ:MXCT)
Price: $2.06
52-Week Range: $1.965 – $5.2
Analyst Upside Potential: 239.81%
Number of Hedge Fund Holders: 12
MaxCyte, Inc. (NASDAQ:MXCT) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 4, MaxCyte, Inc. (NASDAQ:MXCT) announced signing a strategic platform license with Adicet Bio, Inc. Adicet focuses on developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
As part of this agreement, Adicet gets non-exclusive rights to use MaxCyte, Inc.’s (NASDAQ:MXCT) Flow Electroporation technology and ExPERT platform for research, clinical, and commercial purposes. The company has developed a unique process to activate and grow specific gamma delta T cells, enabling large-scale production of off-the-shelf cell therapies ready for clinical use. The approach combines non-viral gene editing with an efficient expansion system to create powerful therapies aimed at treating various cancers and autoimmune conditions. MaxCyte, Inc.’s (NASDAQ:MXCT) ExPERT technology offers advanced electroporation tools that ensure high gene transfer efficiency, cell viability, and scalability.
MaxCyte, Inc. (NASDAQ:MXCT) develops advanced cell-engineering technologies to help biotech and pharmaceutical companies create next-generation cell therapies.
8. WideOpenWest, Inc. (NYSE:WOW)
Price: $3.36
52-Week Range: $3.255 – $5.8
Analyst Upside Potential: 68.15%
Number of Hedge Fund Holders: 13
WideOpenWest, Inc. (NYSE:WOW) is one of the Best 52-Week Low Penny Stocks to Buy Now. On May 29, Matthew Harrigan from Benchmark Co. reduced the price target of WideOpenWest, Inc. (NYSE:WOW) from $7.5 to $6.5, while maintaining a Buy rating on the stock.
The analyst highlighted the company’s recent strategic partnership with Columbus Clingstones to provide exclusive fiber internet services at Synovus. Harrigan believes that the deal highlights the effectiveness of the company’s broadband solutions. He noted that despite a slight reduction in the price target, he remains optimistic that this partnership will enhance WideOpenWest, Inc.’s (NYSE:WOW) financial performance and market presence.
In addition, Harrigan also noted the company’s strong liquidity backed by a recent $200 million credit agreement. This supports the ambitious plan to pass 400,000 new fiber homes by the end of 2027.
WideOpenWest, Inc. (NYSE:WOW) is a broadband provider offering high-speed internet, cable TV, and digital phone services to both residential and business customers.
7. PLAYSTUDIOS, Inc. (NASDAQ:MYPS)
Price: $1.08
52-Week Range: $1.05 – $2.29
Analyst Upside Potential: 131.48%
Number of Hedge Fund Holders: 15
PLAYSTUDIOS, Inc. (NASDAQ:MYPS) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 5, Mike Hickey from Benchmark Co. maintained a Buy rating on PLAYSTUDIOS, Inc. (NASDAQ:MYPS) with a $2 price target.
The analyst reiterated his bullish sentiment on the stock despite a weaker-than-expected second quarter of 2025. PLAYSTUDIOS, Inc. (NASDAQ:MYP) delivered $59.34 million in revenue during the quarter, which dropped 18.26% year-over-year and was also below expectations by $2.29 million. Moreover, the EPS of negative $0.02 also missed the consensus by $0.01. Hickey noted that despite these challenges, management maintained its full-year guidance, showing confidence in its strategy.
Moreover, Hickey highlighted PLAYSTUDIOS, Inc.’s (NASDAQ:MYPS) loyalty-driven ecosystem, particularly its playAWARDS platform, as a competitive edge. He believes that the future growth relies mainly on two speculative projects, including the sweepstakes platform and the Tetris Block Party game.
PLAYSTUDIOS, Inc. (NASDAQ:MYPS) develops free-to-play casual games for mobile and social platforms. Their games range from social casino titles to card and puzzle games.
6. Resources Connection, Inc. (NASDAQ:RGP)
Price: $4.65
52-Week Range: $4.565 – $10.84
Analyst Upside Potential: 50.54%
Number of Hedge Fund Holders: 19
Resources Connection, Inc. (NASDAQ:RGP) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 4, Resources Connection, Inc. (NASDAQ:RGP) announced that its Board of Directors has approved a cash dividend of $0.07 per share, payable on September 26, 2025, to all stockholders on August 29, 2025.
The company also released its fiscal fourth quarter results for 2025 on July 24. The quarter demonstrated mixed results due to an overall tough global market. The revenue for the quarter came in at $139.3 million, down 11.4% year-over-year on a constant currency basis. Management noted that this decline was due to slow decision-making from clients and a sluggish sales cycle. Moreover, total billable hours decreased by 10.5%, but average bill rates rose 4.2%, driven by a shift toward higher-value consulting projects and value-based pricing.
Looking ahead, management remains focused on client relationships and long-term growth with diversified services and brand updates.
Resources Connection, Inc. (NASDAQ:RGP) is a global consulting firm offering specialized services, including expert talent, consulting to improve business processes and technology, finance and accounting outsourcing, and crisis communications.
5. Funko, Inc. (NASDAQ:FNKO)
Price: $3.60
52-Week Range: $3.48 – $14.65
Analyst Upside Potential: 94.44%
Number of Hedge Fund Holders: 21
Funko, Inc. (NASDAQ:FNKO) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 8, D.A. Davidson analyst Keegan Cox lowered the firm’s price target on Funko, Inc. (NASDAQ:FNKO) from $7 to $5, while maintaining a Buy rating on the stock.
The analyst maintained a Buy rating on the stock, noting the return of Michael Lunsford as Interim CEO, which is positive news for the company. He noted that Lunsford has experience in handling restructuring, which indicated that the company might explore strategic alternatives or continue restructuring. Cox believes that steps could position the company for future growth.
Despite this positive news, Cox lowered the firm’s price target on Funko, Inc. (NASDAQ:FNKO) due to softer second-quarter results for 2025. During the quarter, the company’s net sales dropped from $247.7 million to $193.5 million. Moreover, the gross profit also fell to $62.0 million, with a lower gross margin of 32.1% versus 42.0% a year ago. Management noted that this was due to uncertainty coming from tariffs. The company expects the financial position to improve during the second half of the year; however, net sales are expected to be down by high single-digits compared to the second half of 2024.
Funko, Inc. (NASDAQ:FNKO) is a pop culture lifestyle brand that sells licensed consumer products featuring characters from movies, TV shows, video games, music, and sports.
4. TTEC Holdings, Inc. (NASDAQ:TTEC)
Price: $2.94
52-Week Range: $2.83 – $6.28
Analyst Upside Potential: 132.99%
Number of Hedge Fund Holders: 21
TTEC Holdings, Inc. (NASDAQ:TTEC) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 8, William Blair analyst Maggie Nolan maintained a Buy rating on TTEC Holdings, Inc. (NASDAQ:TTEC), without disclosing any price target.
The analyst reiterated his bullish sentiment following the company’s fiscal second quarter 2025 earnings release. Nolan noted that the company exceeded revenue expectations despite a slight 3.8% year-over-year decrease. The company posted a revenue of $513.57 million, which exceeded expectations by $17.64 million. Moreover, TTEC Holdings, Inc. (NASDAQ:TTEC) demonstrated solid growth, particularly in its embedded customer base within the Engage segment. The segment showed a decline but outperformed estimates, driven by AI-driven solutions that improved client retention and growth.
In addition, Nolan also highlighted the company’s cost optimization strategies that led to better operating margins across both its segments. Looking ahead, management raised its full-year outlook and now expects revenue in the range of $2.06 billion to $2.11 billion.
TTEC Holdings, Inc. (NASDAQ:TTEC) provides customer experience technology and services, using artificial intelligence. It operates through two main segments, including the Digital and Engage segments.
3. LifeStance Health Group, Inc. (NASDAQ:LFST)
Price: $3.89
52-Week Range: $3.74 – $8.61
Analyst Upside Potential: 112.08%
Number of Hedge Fund Holders: 24
LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 8, UBS raised the firm’s price target for LifeStance Health Group, Inc. (NASDAQ:LFST) from $8.50 to $9, while maintaining a Buy rating on the stock.
The increased price target follows the company’s fiscal second-quarter earnings release. The company exceeded both revenue and earnings estimates during the quarter. LifeStance Health Group, Inc. (NASDAQ:LFST) posted a revenue of $345.31 million, reflecting a 10.56% year-over-year growth and ahead of estimates by $58,730. Moreover, the EPS of negative $0.01 also beat the analyst consensus by $0.02.
Management noted that they increased the number of clinicians providing care by 11% year-over-year, which led to a 12% increase in visit volumes during the quarter. Looking ahead, management has reaffirmed its full-year revenue guidance in the range of $1.40 billion to $1.44 billion.
LifeStance Health Group, Inc. (NASDAQ:LFST) is a reimagining mental health company that provides both virtual and in-person mental healthcare for children, adolescents, and adults.
2. Myriad Genetics, Inc. (NASDAQ:MYGN)
Price: $3.87
52-Week Range: $3.76 – $29.3
Analyst Upside Potential: 55.04%
Number of Hedge Fund Holders: 26
Myriad Genetics, Inc. (NASDAQ:MYGN) is one of the Best 52-Week Low Penny Stocks to Buy Now. On August 5, Daniel Brennan from TD Cowen maintained a Hold rating on Myriad Genetics, Inc. (NASDAQ:MYGN) with a $6 price target.
The rating follows the company’s fiscal second quarter 2025 earnings release, where the company posted a strong quarter after a weaker first quarter for 2025. Myriad Genetics, Inc. (NASDAQ:MYGN) posted revenue of $213.10 million, reflecting around 1% year-over-year growth and ahead of expectations by $10.8 million. The EPS of $0.05 also exceeded expectations by $0.06.
Brennan noted that this was mainly due to a solid performance in Hereditary Cancer Testing and GeneSight. However, he highlighted that the Prenatal segment remains weak, and the outlook for the second half of 2025 hints at a possible decline in year-over-year growth. The company also faces challenges from the loss of a GeneSight contract and issues with electronic medical records affecting volumes, thereby resulting in a cautious rating from the analyst.
Myriad Genetics, Inc. (NASDAQ:MYGN) is a genetic testing and precision medicine company that develops genetic tests to help assess disease risk and guide treatment decisions.
1. Mereo BioPharma Group plc (NASDAQ:MREO)
Price: $1.63
52-Week Range: $1.57 – $5.02
Analyst Upside Potential: 329.45%
Number of Hedge Fund Holders: 33
Mereo BioPharma Group plc (NASDAQ:MREO) is one of the Best 52-Week Low Penny Stocks to Buy Now. On July 9, Mereo BioPharma Group, along with Ultragenyx Pharmaceutical Inc., announced progress in the Phase 3 Orbit study testing UX143 for osteogenesis imperfecta.
The study is moving toward a final analysis expected around the end of the year. Management noted that the Data Monitoring Committee reviewed the data and found UX143 to have an acceptable safety profile, giving them a go-ahead for the final analysis. Moreover, management also remains confident that increasing UX143 increases bone mass, leading to stronger bones, fewer fractures, and better physical abilities.
Ultragenyx’s CEO, Emil D. Kakkis, noted that while they had hoped to close the trial earlier, they are eager to see complete results from the Orbit and Cosmic studies later this year.
Mereo BioPharma Group plc (NASDAQ:MREO) is a biopharmaceutical company that develops medicines for rare diseases and cancer. The company is working on treatments like Setrusumab for brittle bone disease and alvelestat for severe lung disease.
While we acknowledge the potential of MREO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MREO and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
